Andrew Harkin is Associate Professor of Pharmacology in The School of Pharmacy & Pharmaceutical Sciences in Trinity College Dublin and a principle investigator in Trinity College Institute of Neuroscience. He leads a neuropsychopharmacology research group which is focused on bridging neuroscience to the pharmacological treatment of psychiatric and neurological disorders.
Current research interests include (1) bidirectional nervous system immune interactions, the role of inflammation in the pathogenesis, and potential of anti-inflammatory agents in treating, psychiatric disorders and (2) targeting the N-methyl-D-aspartic acid (NMDA) receptor and the NMDA-nitric oxide-cGMP intra-neuronal signalling in stress related psychiatric disorders.
Assoc. Prof. Harkin’s research program is currently funded by the European Commission (Framework 7 - Brain Imaging Return to Health [r’birth] Marie Curie International Training Network) and the Programme for Research in Third Level Institutions in Ireland (PRTLI) under the auspices of the Higher Education Authority (HEA). The group collaborates widely with a variety of academic and industrial partners on fundamental and clinical projects.